Business · EU
RTÉ
Germany's Merck raises 2026 guidance for third time
German drugmaker Merck has today raised its 2026 core profit guidance for the third time this year, helped by better underlying performance, foreign exchange effects and the acquisition of US firm Bio-Techne.